The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 30, 2008

Filed:

Feb. 12, 2003
Applicants:

Alexander William Oxford, Hertfordshire, GB;

Richard Anthony Borman, Cambridge, GB;

Robert Alexander Coleman, Hertfordshire, GB;

Kenneth Lyle Clark, Cambridge, GB;

George Hynd, Essex, GB;

Janet Ann Archer, Essex, GB;

Amanda Aley, Essex, GB;

Neil Victor Harris, Essex, GB;

Inventors:

Alexander William Oxford, Hertfordshire, GB;

Richard Anthony Borman, Cambridge, GB;

Robert Alexander Coleman, Hertfordshire, GB;

Kenneth Lyle Clark, Cambridge, GB;

George Hynd, Essex, GB;

Janet Ann Archer, Essex, GB;

Amanda Aley, Essex, GB;

Neil Victor Harris, Essex, GB;

Assignee:

Asterand UK Limited, Hertfordshire, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/42 (2006.01); A61K 31/445 (2006.01); A61K 31/55 (2006.01); C07D 263/00 (2006.01); C07D 413/00 (2006.01); C07D 419/00 (2006.01); C07D 403/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to compounds of formula I: wherein one of Rand Ris selected from the group consisting of H, and optionally substituted Calkyl, Ccycloalkyl, Ccycloalkyl-Calkyl, and phenyl-Calkyl; and the other of Rand Ris an optionally substituted Caryl group; Rand Rare either:(i) independently selected from H, R, R', SOR, C(═O)R, (CH)NRR, where n is from 1 to 4 and Rand Rare independently selected from H and R, where R is optionally substituted Calkyl, and R′ is optionally substituted phenyl-Calkyl, or(ii) together with the nitrogen atom to which they are attached, form an optionally substituted Cheterocyclic group; and their use as pharmaceuticals, in particular for treating conditions alleviated by the antagonism of a 5-HTreceptor.


Find Patent Forward Citations

Loading…